Sources: IBM has restarted attempts to sell its unprofitable Watson Health division, potentially for over $1B; IBM has spent $4B on M&A to build Watson Health
IBM has resurrected its sale process for IBM Watson Health, with hopes of fetching more than $1 billion, people familiar with the situation tell Axios.
Context & Ripple Effects
IBM first put Watson Health on the block a year ago, when sources said the roughly $1B-revenue business was unprofitable and up for sale. This report says the process is back on, with IBM hoping to clear $1B — against some $4B spent assembling the unit, including the $2.6B Truven Health Analytics acquisition in 2016.
The timing matters because the arc closes fast: within weeks of this report, sources say IBM agreed to sell part of Watson Health — image software and data sets — to Francisco Partners for $1B+, confirming the discount to invested capital.
First-order effects
- IBM exits an unprofitable ~$1B-revenue division at roughly a quarter of what it paid to build it, removing a drag from its portfolio while keeping its newer bets in quantum and cloud infrastructure.
- Watson Health's imaging software and data sets change hands to a buyer betting a focused owner can run them profitably where a conglomerate could not.
Second-order effects
- Private equity gains a playbook for buying discounted enterprise-AI assets out of big tech, following the Francisco Partners approach to Watson Health's data-rich health-imaging business.
- Rival healthcare-AI vendors face a better-capitalized standalone competitor freed from IBM's cost structure and brand overhang.
Third-order effects
- The pattern — AI divisions assembled through multibillion-dollar M&A failing to reach profitability inside their parents, then sold at steep write-downs — pushes large tech companies toward building fewer acquired conglomerate-AI units and toward divesting the ones they have.
- If PE firms keep absorbing these assets, healthcare AI consolidates around focused operators rather than diversified tech giants, resetting expectations for what 'AI in healthcare' businesses are worth.
The trend: Enterprise AI units built by acquisition are being unwound and sold at deep discounts to invested capital, with private equity replacing big tech as their natural owner.